4/19
08:15 am
rprx
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Low
Report
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
4/17
08:15 am
rprx
Royalty Pharma Declares Second Quarter 2024 Dividend
Low
Report
Royalty Pharma Declares Second Quarter 2024 Dividend
4/12
08:24 am
rprx
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at Bank of America Co. from $40.00 to $38.00. They now have a "buy" rating on the stock.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at Bank of America Co. from $40.00 to $38.00. They now have a "buy" rating on the stock.
4/11
02:04 am
rprx
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/9
01:28 am
rprx
Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring [Yahoo! Finance]
Low
Report
Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring [Yahoo! Finance]
3/30
09:21 am
rprx
Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play? [Yahoo! Finance]
Low
Report
Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play? [Yahoo! Finance]
3/30
02:06 am
rprx
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/26
11:34 am
rprx
Hemato-Oncology Testing Market Size Expected to Reach USD 9.78 Bn by 2033 [Yahoo! Finance]
Low
Report
Hemato-Oncology Testing Market Size Expected to Reach USD 9.78 Bn by 2033 [Yahoo! Finance]
3/22
11:03 pm
rprx
Royalty Pharma plc (NASDAQ: RPRX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/13
08:10 pm
rprx
Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends [Yahoo! Finance]
Low
Report
Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends [Yahoo! Finance]
3/5
11:02 pm
rprx
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/28
04:20 pm
rprx
Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference [Yahoo! Finance]
2/28
04:15 pm
rprx
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Low
Report
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
2/20
12:10 pm
rprx
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $42.00. They now have an "overweight" rating on the stock.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $42.00. They now have an "overweight" rating on the stock.
2/20
10:58 am
rprx
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $56.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $56.00 to $50.00. They now have a "buy" rating on the stock.
2/18
11:35 pm
rprx
Royalty Pharma: Solid Operational Performance [Seeking Alpha]
Low
Report
Royalty Pharma: Solid Operational Performance [Seeking Alpha]
2/18
07:26 am
rprx
Analysts Have Made A Financial Statement On Royalty Pharma plc's (NASDAQ:RPRX) Yearly Report [Yahoo! Finance]
Low
Report
Analysts Have Made A Financial Statement On Royalty Pharma plc's (NASDAQ:RPRX) Yearly Report [Yahoo! Finance]
2/17
07:23 am
rprx
Royalty Pharma Full Year 2023 Earnings: EPS: US$2.54 (vs US$0.098 in FY 2022) [Yahoo! Finance]
Low
Report
Royalty Pharma Full Year 2023 Earnings: EPS: US$2.54 (vs US$0.098 in FY 2022) [Yahoo! Finance]
2/16
05:17 pm
rprx
Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
2/16
09:52 am
rprx
Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/16
12:16 am
rprx
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight [Yahoo! Finance]
Low
Report
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight [Yahoo! Finance]
2/15
08:05 am
rprx
Royalty Pharma PLC (RPRX) Earnings Report: A Detailed Analysis [Yahoo! Finance]
Low
Report
Royalty Pharma PLC (RPRX) Earnings Report: A Detailed Analysis [Yahoo! Finance]
2/15
07:45 am
rprx
Royalty Pharma Reports Q4 and Full Year 2023 Results [Yahoo! Finance]
Low
Report
Royalty Pharma Reports Q4 and Full Year 2023 Results [Yahoo! Finance]
2/15
07:30 am
rprx
Royalty Pharma Reports Q4 and Full Year 2023 Results
Low
Report
Royalty Pharma Reports Q4 and Full Year 2023 Results
1/31
01:21 am
rprx
What Makes Royalty Pharma plc (RPRX) a Compelling Stock? [Yahoo! Finance]
Medium
Report
What Makes Royalty Pharma plc (RPRX) a Compelling Stock? [Yahoo! Finance]